华润医药(03320)：昆药集团前三季度净利润3.23亿元 同比减少35.76%

Core Viewpoint - China Resources Pharmaceutical (03320) reported a decline in revenue and net profit for Kunming Pharmaceutical Group for the nine months ending September 30, 2025, indicating challenges in the company's financial performance [1] Financial Performance - Total revenue for the period was 4.751 billion RMB, representing a year-on-year decrease of 18.08% [1] - Net profit for the same period was 323 million RMB, reflecting a year-on-year decline of 35.76% [1]